Patents by Inventor Dany Doucet

Dany Doucet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Compositions
    Publication number: 20190175701
    Abstract: The present invention provides liquid compositions comprising albiglutide or a variant thereof, a buffering agent, at least one saccharide and/or at least one polyol, at least one stabilizing agent and optionally a surfactant wherein said albiglutide remains stable in said liquid composition. Albiglutide or a variant thereof can be considered to remain stable in liquid if at least about ?96% of said albiglutide or a variant thereof remains as a monomer in the liquid composition over a period of at least one week.
    Type: Application
    Filed: February 25, 2019
    Publication date: June 13, 2019
    Inventors: Liuquan CHANG, Dany Doucet, Douglas P. Nesta
  • Pharmaceutical Compositions
    Publication number: 20180369341
    Abstract: The present invention provides liquid compositions comprising albiglutide or a variant thereof, a buffering agent, at least one saccharide and/or at least one polyol, at least one stabilizing agent and optionally a surfactant wherein said albiglutide remains stable in said liquid composition. Albiglutide or a variant thereof can be considered to remain stable in liquid if at least about ?96% of said albiglutide or a variant thereof remains as a monomer in the liquid composition over a period of at least one week.
    Type: Application
    Filed: September 11, 2018
    Publication date: December 27, 2018
    Inventors: Liuquan CHANG, Dany DOUCET, Douglas P. NESTA
  • Pharmaceutical Composition
    Publication number: 20180021409
    Abstract: The present invention provides liquid compositions comprising albiglutide or a variant thereof, a buffering agent, at least one saccharide and/or at least one polyol, at least one stabilizing agent and optionally a surfactant wherein said albiglutide remains stable in said liquid composition. Albiglutide or a variant thereof can be considered to remain stable in liquid if at least about ?96% of said albiglutide or a variant thereof remains as a monomer in the liquid composition over a period of at least one week.
    Type: Application
    Filed: June 23, 2015
    Publication date: January 25, 2018
    Inventors: Liuquan CHANG, Dany DOUCET, Douglas P. NESTA
  • Composition and Method for Increasing Cell Permeability of a Compound
    Publication number: 20100160209
    Abstract: The invention provides for a cell permeable peptide conjugated to an insulin compound for improved cell penetration of the insulin moiety. The composition may be delivered by intravenous, intramuscular, subcutaneous, intranasal, oral inhalation, intrarectal, intravaginal or intraperitoneal means for the treatment, including prophylaxis of Type I, Type II diabetes, prediabetes and/or metabolic syndrome.
    Type: Application
    Filed: May 10, 2007
    Publication date: June 24, 2010
    Applicant: SmithKline Beecham Corporation
    Inventors: Dany Doucet, Mickey Lee Wells